SCHEMBL30456932

SCHEMBL30456932

CCCCC(C)(C)OOC(C)(C)OC(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAM P19021 2/20 0.31
CA2 P00918 1/20 0.31
MAPK1 P28482 1/20 0.31
AKR1B1 P15121 1/20 0.30
GMNN O75496 1/20 0.30
USP2 O75604 1/20 0.30
CYP1A2 P05177 1/20 0.30
POLB P06746 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
APEX1 P27695 1/20 0.30
CYP2C19 P33261 1/20 0.30
RECQL P46063 1/20 0.30
BLM P54132 1/20 0.30
HSD17B10 Q99714 1/20 0.30
CTSK P43235 1/20 0.30
KMT2A Q03164 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8438760 0.89 LMNA (0.33) HSD17B10
Bicarbonate SCHEMBL25202235 0.87 LMNA (0.32) HSD17B10
SCHEMBL31094246 0.82 TSHR (0.36) HSD17B10
SCHEMBL608106 0.82 CA2 (0.36) PAMCA2MAPK1AKR1B1HSD17B10
Ammonia Solution, Strong SCHEMBL29208117 0.80 CA2 (0.35) PAMCA2MAPK1AKR1B1GMNN
SCHEMBL2912856 0.80 TSHR (0.33) CYP1A2CYP2D6CYP2C19TDP1
SCHEMBL31094245 0.79 LMNA (0.30) HSD17B10
SCHEMBL1069757 0.79 PAM (0.33) PAMCA2MAPK1AKR1B1HSD17B10
SCHEMBL2311514 0.77 ALDH1A1 (0.35) CYP2C19HSD17B10TDP1
SCHEMBL8039291 0.77 TSHR (0.35) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692177-A1 RESIN POWDER AND METHOD FOR PRODUCING SAME Kaneka Corporation (JP) 2026-02-11 EP disclosed
US-20250388748-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-12-25 US disclosed
EP-4610313-A1 THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2025-09-03 EP disclosed
US-20250250435-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-08-07 US disclosed
US-20250243321-A1 METHOD FOR PRODUCING MODIFIED ALIPHATIC OR ALIPHATIC-AROMATIC THERMOPLASTIC POLYESTER RESIN KANEKA CORPORATION (JP) 2025-07-31 US disclosed
US-20250230273-A1 CROSSLINKED RESIN PARTICLES AND METHOD FOR PRODUCING THE SAME KANEKA CORPORATION (JP) 2025-07-17 US disclosed
US-20250215215-A1 THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2025-07-03 US disclosed
WO-2025075125-A1 BLOW-MOLDED ARTICLE AND METHOD FOR PRODUCING SAME 株式会社カネカ 2025-04-10 WO disclosed
WO-2025075117-A1 THERMOPLASTIC RESIN COMPOSITION AND USE THEREOF 株式会社カネカ 2025-04-10 WO disclosed
WO-2025075116-A1 THERMOPLASTIC RESIN COMPOSITION AND USE THEREOF 株式会社カネカ 2025-04-10 WO disclosed
EP-4502081-A1 THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2025-02-05 EP disclosed
EP-4467589-A1 MODIFIED ALIPHATIC POLYESTER-BASED RESIN AND COMPOSITION OR MOLDED BODY THEREOF Kaneka Corporation (JP) 2024-11-27 EP disclosed
EP-4467590-A1 METHOD FOR MANUFACTURING MODIFIED ALIPHATIC OR ALIPHATIC AROMATIC THERMOPLASTIC POLYESTER RESIN Kaneka Corporation (JP) 2024-11-27 EP disclosed
WO-2024203745-A1 RESIN POWDER AND METHOD FOR PRODUCING SAME 株式会社カネカ 2024-10-03 WO disclosed
WO-2024090484-A1 THERMOPLASTIC RESIN COMPOSITION 株式会社カネカ 2024-05-02 WO disclosed
US-20230323114-A1 ALIPHATIC-POLYESTER-BASED RESIN COMPOSITION AND UTILIZATION THEREOF KANEKA CORPORATION (JP) 2023-10-12 US disclosed
WO-2023190185-A1 THERMOPLASTIC RESIN COMPOSITION 株式会社カネカ 2023-10-05 WO disclosed
WO-2023190184-A1 THERMOPLASTIC RESIN COMPOSITION 株式会社カネカ 2023-10-05 WO disclosed
WO-2023190183-A1 CROSSLINKED RESIN PARTICLES AND METHOD FOR PRODUCING SAME 株式会社カネカ 2023-10-05 WO disclosed
EP-4183828-A1 ALIPHATIC-POLYESTER-BASED RESIN COMPOSITION AND UTILIZATION THEREOF Kaneka Corporation (JP) 2023-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388748-A1 THERMOPLASTIC RESIN COMPOSITION HSPA4L, HSP90AA1, HACD3 PAM 3131/4885CA2 2284/4885MAPK1 4186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.